NCT06966258 Inspire HER: Inspiring the Heart and Emotions for Radical Health
| NCT ID | NCT06966258 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Cardiovascular-kidney-metabolic Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-11-15 |
| Primary Completion | 2029-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-11-15 with a primary completion date of 2029-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Poor heart health puts Black women at risk for a shorter life with more illness than people of any other non-indigenous racial group. We will refine and conduct a randomized, wait-list controlled trial of Inspire HER (a heart health lifestyle intervention for Black women that provides health education, physical activity, and social resources). We will also compare Inspire HER and Black Impact (a heart health intervention for Black men) data to study how women and men respond differently to stress. This trial aligns with American Heart Association's pledge to address heart health equity through new interventions that consider the person and the circumstances with which they live.
Eligibility Criteria
Inclusion Criteria: * Black women (self-report) * Adult ages 30-79 years * Stage 2 or greater Cardiovascular-Kidney-Metabolic Syndrome * English speaking * Lives in Metropolitan Birmingham, AL area. Exclusion Criteria: \- Healthcare provider-imposed physical activity limitations.
Contact & Investigator
Timiya S Nolan, PhD
PRINCIPAL INVESTIGATOR
University to Alabama at Birmingha
Frequently Asked Questions
Who can join the NCT06966258 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 79 Years, studying Cardiovascular-kidney-metabolic Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06966258 currently recruiting?
Yes, NCT06966258 is actively recruiting participants. Contact the research team at leandreaanderson@uabmc.edu for enrollment information.
Where is the NCT06966258 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT06966258 clinical trial?
NCT06966258 is sponsored by University of Alabama at Birmingham. The principal investigator is Timiya S Nolan, PhD at University to Alabama at Birmingha. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.